“Prognostic
and Diagnostic Glycan-based Biomarkers of Brain Damage” Granted European Patent No. 3283880.
“Non-invasive
brain injury diagnostic device” U.S. Patent
application No. 62/461,277, WO2018154401; National applications pending
”Device and method for detecting of brain injury in a subject” Filed as FI 20196004
”A method for determining a lectin binding glycan indicative to traumatic brain injury” US application 16/840,931.
NCE portfolio
”Multivalent
compounds for use in the treatment and prevention of brain damage" Granted Finnish patent FI
127 024; Granted US patent US 9,975,846; Israeli patent (final stage)
”Compositions, and compositions for use in preventing or
treating of brain damage and neurodegenerative diseases” Filed as FI 20195715